Table 2.
The relationship between POR expression and clinicopathological factors in the cohort 2.
| Variable | POR expression | P-value* | ||
|---|---|---|---|---|
| Low | High | |||
| Gender | Male | 86 | 97 | 0.046 |
| Female | 20 | 9 | ||
| Age | ≤50years | 51 | 58 | 0.410 |
| >50years | 55 | 48 | ||
| ALT | ≤50U/L | 59 | 65 | 0.486 |
| >50U/L | 47 | 41 | ||
| AFP | ≤300ng/ml | 40 | 75 | <0.001 |
| >300ng/ml | 65 | 29 | ||
| BCLC | 0/A | 74 | 89 | 0.023 |
| B/C | 32 | 17 | ||
| Cirrhosis | No | 6 | 11 | 0.312 |
| Yes | 100 | 95 | ||
Abbreviations: ALT, alanine aminotransferase; AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer stage. Note: *P-value was calculated using two-sided χ2 test.